Menu
Back to User profile » Dr Xi Zhang
Papers published by Dr Xi Zhang:
Prognostic Roles of Inflammation- and Nutrition-Based Indicators for Female Patients with Cancer
Yang M, Zhang Q, Ge Y, Tang M, Hu C, Wang Z, Zhang X, Song M, Ruan G, Zhang X, Liu T, Xie H, Zhang H, Zhang K, Li Q, Li X, Liu X, Lin S, Shi H
Journal of Inflammation Research 2022, 15:3573-3586
Published Date: 17 June 2022
Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi- Center Cohort Study
Xie H, Ruan G, Zhang Q, Ge Y, Song M, Zhang X, Liu X, Lin S, Zhang X, Li X, Zhang K, Yang M, Tang M, Cong M, Shi H
Journal of Inflammation Research 2022, 15:1005-1015
Published Date: 15 February 2022
One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein
Liu XY, Zhang X, Ruan GT, Zhang KP, Tang M, Zhang Q, Song MM, Zhang XW, Ge YZ, Yang M, Xu HX, Song CH, Shi HP
Cancer Management and Research 2021, 13:6775-6783
Published Date: 29 August 2021
Relationship Between Prognostic Nutritional Index and Mortality in Overweight or Obese Patients with Cancer: A Multicenter Observational Study
Zhang X, Li JH, Zhang Q, Li QQ, Zhang KP, Tang M, Ge YZ, Li W, Xu HX, Guo ZQ, Shi HP
Journal of Inflammation Research 2021, 14:3921-3932
Published Date: 14 August 2021
Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
Yu J, Zhang X, Huang Q, Tan S, Xiong X, Gou H
Cancer Management and Research 2021, 13:4283-4290
Published Date: 31 May 2021
The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials
Guo XX, Wu HL, Shi HY, Su L, Zhang X
Cancer Management and Research 2018, 10:2553-2562
Published Date: 10 August 2018
Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials
Zhou JX, Feng LJ, Zhang X
Drug Design, Development and Therapy 2017, 11:3009-3017
Published Date: 13 October 2017
Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis
Zhang X, Ran Y, Wang K, Zhu Y, Li J
Drug Design, Development and Therapy 2016, 10:3153-3161
Published Date: 28 September 2016